Phase III trial of intranasal dexmedetomidine in patients with acute postoperative pain.

Trial Profile

Phase III trial of intranasal dexmedetomidine in patients with acute postoperative pain.

Withdrawn prior to enrolment
Phase of Trial: Phase III

Latest Information Update: 26 Oct 2015

At a glance

  • Drugs Dexmedetomidine (Primary)
  • Indications Postoperative pain
  • Focus Therapeutic Use
  • Sponsors Recro Pharma
  • Most Recent Events

    • 26 Oct 2015 According to Recro Pharma media release, the company has decided not to continue with the clinical program for Dex-IN in post operative pain after feedback from FDA on the phase II efficacy and safety data. It intends to pursue a phase II program in peri-procedural pan instead.
    • 26 Oct 2015 Status changed from planning to withdrawn prior to enrolment, based on the information in the Recro Pharma media release.
    • 27 Mar 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top